BioSpace News Archive

Nabriva Therapeutics plc, a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, announced that Ted Schroeder, Chief Executive Offer at Nabriva, will provide a company overview and business update at the Jefferies Virtual Healthcare Conference on Thursday, June 3, at 2:30 p.m. ET.

Amicus Therapeutics, announced two posters for presentation highlighting its development program for Pompe disease at the 16th International Congress on Neuromuscular Diseases being held virtually, May 21-22 and 28-29, 2021.

Sierra Oncology, Inc., a late-stage biopharmaceutical company on a quest to deliver targeted therapies that treat rare forms of cancer, granted a stock option to a new employee as approved by the Compensation Committee of the Company’s Board of Directors, under Sierra Oncology’s 2018 Equity Inducement Plan.

Tislelizumab combined with chemotherapy demonstrated a statistically significant improvement in progression-free survival at the interim analysis

Collaboration aims to develop a next-generation AAV production platform to help accelerate Biogen’s efforts to bring novel gene therapies to patients worldwide Ginkgo’s synthetic biology expertise may enable the expansion of therapeutic utility and overcome development challenges of viral vectors for gene therapy Ginkgo to receive $5 million upfront payment and is eligible for up to $115 million in potential research, development, and commercial milestones

Wesana Health Holdings Inc., an emerging data-driven life sciences company focused on developing innovative approaches for better understanding, protecting and improving neurological health and performance, including through the advancement of psychedelic medicines, announced the expansion of its executive leadership team with the hire of Mark Wingertzahn, PhD, as Chief Scientific Officer.

Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that the Company will host a webinar highlighting DCCR (diazoxide choline) Extended-Release tablets for the treatment of Prader-Willi syndrome (PWS) at the 23 rd European Congress of Endocrinology 2021, on Monday, May 24, 2021, at 8:15 AM Central European Summer Time

Exact Sciences Corp. (NASDAQ: EXAS) today highlights data from one oral and one poster presentation being featured at the 2021 Digestive Disease Week® (DDW®) virtual annual meeting, taking place May 21-23

Transparency Market Research has published a new report titled ‘Vaginal Slings Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.’ According to the report, the global vaginal slings market was valued at US$ 1,676.0 Mn in 2017.

The global microdermabrasion devices market was valued at around US$ 150 Mn in 2017.